New avenue for anti-depressant therapy discovered

New avenue for anti-depressant therapy discovered
Credit: Academy of Finland

Researchers have made a ground-breaking discovery revealing new molecular information on how the brain regulates depression and anxiety. In so doing, they identified a new molecule that alleviates anxiety and depressive behaviour in rodents. The research, led by Eleanor Coffey, Research Director at Åbo Akademi University in Finland is a collaborative effort between scientists in Finland and the US.

The researchers found that a protein called JNK when active, represses the generation of new neurons in the hippocampus, a part of the brain that controls emotions and learning. By inhibiting JNK solely in newly generated nerve cells in the hippocampus, the were able to alleviate and depressive behaviour in mice. This previously unknown mechanism brings fresh insight on how the brain works to regulate mood and indicates that inhibitors of JNK, such as the one used here, can provide a new avenue for anti-depressant and anxiolytic drug development.

Depression and anxiety are highly prevalent disorders and represent one of the largest causes of disability worldwide. These results are important as many patients do not respond to current treatments and it has long been recognised that new mechanistic understanding of these disorders would be necessary to in order to identify drugs for .

The research was funded by the EU-funded Marie Curie Initial Training Network r'BIRTH, by the Academy of Finland, Turku Network in Molecular Biosciences and the National Institute on Aging (US). The results are published in the Nature Publishing Group journal Molecular Psychiatry.

Researchers used virus tools to find out where in the brain the JNK inhibitor acted to improve mood. They found out the molecule acts to alleviate anxiety and depression by controlling newly born in the hippocampus. The image, taken at the Cell Imaging Core, shows these new born cells in the hippocampus, the region of the that controls emotions.


Explore further

Enzyme research provides a new picture of depression

More information: H Mohammad et al. JNK1 controls adult hippocampal neurogenesis and imposes cell-autonomous control of anxiety behaviour from the neurogenic niche, Molecular Psychiatry (2016). DOI: 10.1038/mp.2016.203
Journal information: Molecular Psychiatry

Provided by Academy of Finland
Citation: New avenue for anti-depressant therapy discovered (2017, January 18) retrieved 14 November 2019 from https://medicalxpress.com/news/2017-01-avenue-anti-depressant-therapy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
15 shares

Feedback to editors

User comments